882 related articles for article (PubMed ID: 29550938)
1. In vivo relationship between serotonin 1A receptor binding and gray matter volume in the healthy brain and in major depressive disorder.
Zanderigo F; Pantazatos S; Rubin-Falcone H; Ogden RT; Chhetry BT; Sullivan G; Oquendo M; Miller JM; Mann JJ
Brain Struct Funct; 2018 Jul; 223(6):2609-2625. PubMed ID: 29550938
[TBL] [Abstract][Full Text] [Related]
2. Serotonin-1A receptor binding is positively associated with gray matter volume -- a multimodal neuroimaging study combining PET and structural MRI.
Kraus C; Hahn A; Savli M; Kranz GS; Baldinger P; Höflich A; Spindelegger C; Ungersboeck J; Haeusler D; Mitterhauser M; Windischberger C; Wadsak W; Kasper S; Lanzenberger R
Neuroimage; 2012 Nov; 63(3):1091-8. PubMed ID: 22836176
[TBL] [Abstract][Full Text] [Related]
3. Higher 5-HT
Milak MS; Pantazatos S; Rashid R; Zanderigo F; DeLorenzo C; Hesselgrave N; Ogden RT; Oquendo MA; Mulhern ST; Miller JM; Burke AK; Parsey RV; Mann JJ
Psychiatry Res Neuroimaging; 2018 Jun; 276():15-23. PubMed ID: 29702461
[TBL] [Abstract][Full Text] [Related]
4. Quantification of the Serotonin 1A Receptor Using PET: Identification of a Potential Biomarker of Major Depression in Males.
Kaufman J; Sullivan GM; Yang J; Ogden RT; Miller JM; Oquendo MA; Mann JJ; Parsey RV; DeLorenzo C
Neuropsychopharmacology; 2015 Jun; 40(7):1692-9. PubMed ID: 25578798
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography quantification of serotonin(1A) receptor binding in suicide attempters with major depressive disorder.
Sullivan GM; Oquendo MA; Milak M; Miller JM; Burke A; Ogden RT; Parsey RV; Mann JJ
JAMA Psychiatry; 2015 Feb; 72(2):169-78. PubMed ID: 25549105
[TBL] [Abstract][Full Text] [Related]
6. Brain structural alterations in MDD patients with gastrointestinal symptoms: Evidence from the REST-meta-MDD project.
Liu PH; Li Y; Zhang AX; Sun N; Li GZ; Chen X; Bai TJ; Bo QJ; Chen GM; Chen NX; Chen TL; Chen W; Cheng C; Cheng YQ; Cui XL; Duan J; Fang YR; Gong QY; Guo WB; Hou ZH; Hu L; Kuang L; Li F; Li KM; Li T; Liu YS; Liu ZN; Long YC; Luo QH; Meng HQ; Peng DH; Qiu HT; Qiu J; Shen YD; Shi YS; Wang F; Wang K; Wang L; Wang X; Wang Y; Wu XP; Wu XR; Xie CM; Xie GR; Xie HY; Xie P; Xu XF; Yang H; Yang J; Yao JS; Yao SQ; Yin YY; Yuan YG; Zhang H; Zhang L; Zhang ZJ; Zhou RB; Zhou YT; Zhu JJ; Zou CJ; Si TM; Zuo XN; Yan CG; Zhang KR
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110386. PubMed ID: 34119573
[TBL] [Abstract][Full Text] [Related]
7. Gray Matter Abnormalities in Non-comorbid Medication-naive Patients with Major Depressive Disorder or Social Anxiety Disorder.
Zhao Y; Chen L; Zhang W; Xiao Y; Shah C; Zhu H; Yuan M; Sun H; Yue Q; Jia Z; Zhang W; Kuang W; Gong Q; Lui S
EBioMedicine; 2017 Jul; 21():228-235. PubMed ID: 28633986
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression.
Sullivan GM; Ogden RT; Oquendo MA; Kumar JS; Simpson N; Huang YY; Mann JJ; Parsey RV
Biol Psychiatry; 2009 Aug; 66(3):223-30. PubMed ID: 19278673
[TBL] [Abstract][Full Text] [Related]
9. No association between serotonin 5-HT 1A receptors and spirituality among patients with major depressive disorders or healthy volunteers.
Karlsson H; Hirvonen J; Salminen JK; Hietala J
Mol Psychiatry; 2011 Mar; 16(3):282-5. PubMed ID: 19935737
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant medication exposure and 5-HT
Metts AV; Rubin-Falcone H; Ogden RT; Lin X; Wilner DE; Burke AK; Sublette ME; Oquendo MA; Miller JM; Mann JJ
Synapse; 2019 Jun; 73(6):e22089. PubMed ID: 30693567
[TBL] [Abstract][Full Text] [Related]
11. Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging.
Baldinger P; Höflich AS; Mitterhauser M; Hahn A; Rami-Mark C; Spies M; Wadsak W; Lanzenberger R; Kasper S
Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522403
[TBL] [Abstract][Full Text] [Related]
12. Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder.
Miller JM; Hesselgrave N; Ogden RT; Zanderigo F; Oquendo MA; Mann JJ; Parsey RV
Biol Psychiatry; 2013 Nov; 74(10):760-7. PubMed ID: 23664414
[TBL] [Abstract][Full Text] [Related]
13. An Association Between Serotonin 1A Receptor, Gray Matter Volume, and Sociability in Healthy Subjects and in Autism Spectrum Disorder.
Lefevre A; Richard N; Mottolese R; Leboyer M; Sirigu A
Autism Res; 2020 Nov; 13(11):1843-1855. PubMed ID: 32864880
[TBL] [Abstract][Full Text] [Related]
14. Higher in vivo serotonin-1a binding in posttraumatic stress disorder: a PET study with [11C]WAY-100635.
Sullivan GM; Ogden RT; Huang YY; Oquendo MA; Mann JJ; Parsey RV
Depress Anxiety; 2013 Mar; 30(3):197-206. PubMed ID: 23408467
[TBL] [Abstract][Full Text] [Related]
15. Serotonin-1A receptor imaging in recurrent depression: replication and literature review.
Drevets WC; Thase ME; Moses-Kolko EL; Price J; Frank E; Kupfer DJ; Mathis C
Nucl Med Biol; 2007 Oct; 34(7):865-77. PubMed ID: 17921037
[TBL] [Abstract][Full Text] [Related]
16. Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET.
Lanzenberger R; Baldinger P; Hahn A; Ungersboeck J; Mitterhauser M; Winkler D; Micskei Z; Stein P; Karanikas G; Wadsak W; Kasper S; Frey R
Mol Psychiatry; 2013 Jan; 18(1):93-100. PubMed ID: 22751491
[TBL] [Abstract][Full Text] [Related]
17. Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635.
Hirvonen J; Karlsson H; Kajander J; Lepola A; Markkula J; Rasi-Hakala H; Någren K; Salminen JK; Hietala J
Int J Neuropsychopharmacol; 2008 Jun; 11(4):465-76. PubMed ID: 17971260
[TBL] [Abstract][Full Text] [Related]
18. Regional brain volume reductions in major depressive disorder and bipolar disorder: An analysis by voxel-based morphometry.
Niida R; Yamagata B; Matsuda H; Niida A; Uechi A; Kito S; Mimura M
Int J Geriatr Psychiatry; 2019 Jan; 34(1):186-192. PubMed ID: 30328161
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal brain volume changes in major depressive disorder.
Yüksel D; Engelen J; Schuster V; Dietsche B; Konrad C; Jansen A; Dannlowski U; Kircher T; Krug A
J Neural Transm (Vienna); 2018 Oct; 125(10):1433-1447. PubMed ID: 30167933
[TBL] [Abstract][Full Text] [Related]
20. Large-scale network dynamics in neural response to emotionally negative stimuli linked to serotonin 1A binding in major depressive disorder.
Schneck N; Tu T; Falcone HR; Miller JM; Zanderigo F; Sublette ME; Oquendo MA; Stanley B; Burke A; Ochsner K; Sajda P; John Mann J
Mol Psychiatry; 2021 Jun; 26(6):2393-2401. PubMed ID: 32355333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
